key: cord-0984012-k7njyvf1 authors: Feter, Natan; Caputo, Eduardo L.; Leite, Jayne S.; Smith, Emily C.; Doring, Igor R.; Cassuriaga, Júlia; Delpino, Felipe Mendes; Huckembeck, Caroline Maluê; Alt, Ricardo; Reichert, Felipe F.; da Silva, Marcelo C.; Coombes, Jeff S.; Rombaldi, Airton J. title: Depression and anxiety symptoms remained elevated after 10 months of the COVID-19 pandemic in southern Brazil: findings from the PAMPA cohort date: 2021-12-30 journal: Public Health DOI: 10.1016/j.puhe.2021.12.019 sha: 079c9973deb2a8c70b991961ef6414ab857dc159 doc_id: 984012 cord_uid: k7njyvf1 Objective To examine the changes in depression and anxiety symptoms among Brazilian adults over 10 months of the COVID-19 pandemic. Study design The present study used data from wave 1 (June/July, 2020) and wave 2 (December, 2020/January, 2021) of the Prospective Study About Mental and Physical Health (PAMPA) Cohort, a state-level, ambispective longitudinal study with adults from southern Brazil. The frequency of anxiety and depressive symptoms was assessed using the Hospital Anxiety and Depression Scale (HADS). Anxiety and depressive symptoms before social distancing were retrospectively assessed during wave 1. Results Most of the 674 participants were classified as non-symptomatic for depressive (85.0%) and anxiety symptoms (73.2%) before the COVID-19 pandemic. At wave 1 there were increases in symptoms of depression (7.6% [95%CI: 7.2%; 8.1%]) and anxiety (9.1% [95%CI: 8.6%; 9.5%]). These decreased at wave 2 (depression: 6.9% [95%CI: 6.5%; 7.2%]; anxiety: 7.4% [95%CI: 7.1%; 7.8%]) although they were still elevated compared to pre-COVID (depression: 4.5% [95%CI: 4.2%; 4.8%]; anxiety: 5.8% [95%CI: 5.5%; 6.1%]). Adults living alone (b=0.44 [95%CI: 0.07; 0.82]) had a faster trajectory in anxiety symptoms than their counterparts. Cohort members who were living alone (b=0.24 [95%CI: 0.06; 0.42]) and with diagnosed chronic disease (0.32 [95%CI: 0.18; 0.46]) had a faster increase in depressive symptoms than their respective counterparts. Participants aged 60 or showed a slower trajectory of depressive (b= -0.46 [95%CI: -0.73; -0.18]) and anxiety (b=-0.61 [95%CI: -1.20; -0.02) symptoms. Conclusions During 10 months of COVID-19 anxiety and depression symptoms improved but were still higher than before COVID-19. The new coronavirus disease had the first case reported in late December 2019 in China. Since then, over 154 million cases had been recorded worldwide, with the United States and Brazil accounting for roughly one-third of the number of people diagnosed with COVID-19 1 . Also, millions of people had lost their lives due to this disease in the world. Further, robust healthcare systems have been disrupted due to the sharp and rapid increase in hospitalizations due to COVID-19 2 . As disease-modifying treatments have not been developed before 2021, nonpharmacological strategies to mitigate virus transmission such as social distancing has been used 3 . Social distancing has been proven to be an efficient approach at the population level to lessen the number of cases, deaths, and hospitalizations attributed to COVID-19 4 . However, it also has been associated with other effects such as aggravated symptoms of anxiety and depression 5, 6 . To identify the effects of social distancing on mental and physical health in adults from southern Brazil, the PAMPA (Prospective Study About Mental and Physical Health) Cohort was created 7 . Using data from wave 1 carried out between June and July 2020, we observed that cases of moderate-to-severe anxiety and depressive symptoms had increased by J o u r n a l P r e -p r o o f 7.4 and 6.6-fold respectively 8 . These increases were even higher than those observed in countries where more restrictive strategies (e.g., lockdown) were adopted [9] [10] [11] . Sociodemographic and health-related factors including female sex, age (≤45 years), presence of a chronic disease and physical inactivity have been identified as risk factors for higher levels of depressive and anxiety symptoms during the pandemic 5, 6, 9, 10, 12, 13 . However, individual repeated-measures data to quantify the longitudinal changes on anxiety and depressive symptoms since the beginning of social distancing are scarce 14 . This gap limits our knowledge as to whether these symptoms are still elevated, have increased even more or have diminished after several months into the COVID-19 pandemic. For example, data from the United Kingdom 15 and Germany 16 showed that the rapid increase in depressive and anxiety symptoms observed in March, 2020 were followed by a decline up to five months later. Thus, we aimed to examine the changes in depression and anxiety symptoms among Brazilian adults over 10 months of the COVID-19 pandemic. Based on previous longitudinal studies with shorter follow-up 15, 16 , we hypothesized that the frequency of anxiety and depressive symptoms would remain elevated although stable in our cohort in the second half of 2020. The present study used data from the first two waves of the PAMPA (Prospective Study About Mental and Physical Health) Cohort, a state-level, ambispective longitudinal study with adults from southern Brazil. A full description of the PAMPA cohort can be found elsewhere 7 . The study protocol was approved by the Adults living in the Rio Grande do Sul state were recruited via personal networks, social and local media 7, 17 . Data were collected using an online-based, self-reported questionnaire. In wave 1, recruitment lasted four weeks (June 22 nd , 2020 -July 23 rd , 2020), while in wave 2 it was over seven weeks because it included the holiday period (December 1 st 2020 -January 15 th 2021). Both sets of data collection were performed exclusively online. The Rio Grande do Sul state is divided into regions by the government and each region is weekly classified into one of the four flag colors (i.e., yellow, orange, red, black), based on the current number of COVID-19 cases and the rate of contamination as well as the capacity of the health system to attend to the population of the region. The yellow flag indicates a region that has low risk of transmission and hospital occupancy rate, and a high availability of intensive care units (ICU) while the black flag indicates a region with high risk of transmission and hospital occupancy rate and a low ICU availability. Regions rated with a black flag have the most restrictive measures to limit virus spread. Up to 73.5% and 95.2% of the state's population were rated with red flag during waves 1 and 2, respectively, as defined by the State government's social distancing policies. During this level of restrictions, social clubs, gyms, theaters, religious temples, commercial activities, and malls were allowed to open, but with maximal capacity reduced by up to 75% to prevent gatherings. J o u r n a l P r e -p r o o f The required sample size calculated before wave 1 was based on the prevalence of depression in the Rio Grande do Sul state in 2013 (13.2%; 95% confidence interval The frequency of anxiety and depressive symptoms was assessed using the Hospital Anxiety and Depression Scale (HADS). This instrument was previously validated in both primary care and community settings [19] [20] [21] [22] . The scale is composed by two domains (anxiety and depression), with seven items, each scoring from 0 to 3. Thus, each domain has a maximum score of 21 points, with higher scores indicating higher frequency of symptoms. Participants who scored seven or less were classified as non-symptomatic for that domain. Scores between 8 and 10 were J o u r n a l P r e -p r o o f considered as mild risk, between 11 and 14 as moderate risk, and higher than 15 as severe risk of anxiety or depression 20 . In wave 1, participants were asked to rate the frequency of depressive and anxiety symptoms twice. First, we explored depression and anxiety retrospectively by asking the participant to answer the HADS as if they were two months before (i.e., before the COVID-19 pandemic). Second, they responded to that same questionnaire but referred to the last two weeks. In wave 2, these symptoms were assessed using the HADS with the last two weeks as the reference period. Sociodemographic characteristics, including age, gender, skin color, conjugal situation, and educational level, were assessed in wave 1. We also asked participants in wave 1 how social distancing affected their monthly income (i.e., decreased, unchanged, increased). Self-reported weight and height were reported to calculate body mass index (BMI). BMI was further categorized into normal (BMI<25 kg/m 2 ), overweight (BMI ≥25 and <30 kg/m 2 ), and obese (BMI ≥30 kg/m 2 ). Chronic diseases diagnosed by a physician were also reported during wave 1 using the question previously used in the Brazilian Telephone-based Surveillance System for Noncommunicable Diseases 23 . In wave 1 physical activity before social distancing and during the current week were determined. In wave 2, the reference period for physical activity was the current week. The following validated question was used 24 Respondents with less than 150 minutes of physical activity per week were classified as inactive, and those with 150 minutes or more were considered physically active. We also asked participants about the use of online services to practice home-based physical activity during wave 2. Due to the overrepresentation of respondents from one macroregion in the state (Sul, N=436, 64.6%), all analyzes were weighted by the respondents' proportion in each macroregion. Normality of data distribution and homoscedasticity were tested using Shapiro-Wilk and Bartlett tests, respectively. Continuous data were reported as mean and 95%CI, while categorical variables were shown as proportions and 95%CI. Differences between excluded and included participants were tested using the chi-square test. Two-way analysis of covariance with repeated measures was used to compare HADS scores among the three periods, with P-values adjusted for multiple comparisons using the Bonferroni's post-hoc. We further used structural equation modelling with maximum likelihood method to identify the velocity of change on depressive and anxiety symptoms over 10 months of the COVID-19 pandemic. The slope and intercept of the model for each domain (i.e., anxiety and depression) were integrated into multivariate linear regression models. A significant intercept indicates between-group differences before COVID-19 social distancing. Positive and negative slope coefficients indicated the trajectory of the symptoms was faster or slower, respectively, than the reference groups. All variables from univariate analyzes were added in the multivariate model, and a Pvalue ≤0.20 was set to determine whether variables were maintained in the model. We adopted a P-value lower than 0.05 as the level of significance. All analyzes were performed using STATA/MP 14.2 (Stata Corp, College Station, Texas). From the participants included in wave 1 (n=2,321), 1,302 were available for wave 2, as shown in Figure 1 . A total of 674 (51.8% of the available sample) individuals participated in both waves and were included in this analysis. Eligible participants who were lost-to-follow-up in wave 2 were more likely to be older than 30 years old (p=0.005), as shown in Supplementary Table 1 Table 2 illustrates the scores from the HADS depression-specific domain. Significant time x group interactions were observed based on age groups (p<0.001), conjugal situation (p=0.003), and depressive (p<0.001), and anxiety (p=0.014) symptoms before the pandemic. People aged younger than 60 years reported an increased and sustained frequency of depressive symptoms over 10 months of the COVID-19 pandemic. On the other hand, no significant changes were observed among people aged 60 years or more and those with moderate-to-severe depressive symptoms. During social distancing, participants who lived with a partner showed a lower score on depressive symptoms than those who lived alone. Participants who were non-symptomatic for depressive symptoms before social distancing reported a higher score on the depression-specific HADS domain during wave 1 followed by a reduction in wave 2. However, scores in wave 2 remained elevated compared to before the pandemic. Participants with a mild risk of depression showed elevated scores in waves 1 and 2 with no significant difference between these two time points. No interaction effect was observed for other variables. ---Insert Figure 2 here---Changes on anxiety symptoms over 10 months of the COVID-19 pandemic are reported in Supplementary Table 3 . Younger participants (i.e., < 60 years) had higher scores of anxiety-specific HADS in wave 1 followed by a significant reduction in wave 2 though still higher than before the pandemic. A similar pattern was observed among participants non-symptomatic for anxiety levels before the pandemic. Those with a mild risk for anxiety showed increased scores in wave 1 with J o u r n a l P r e -p r o o f no reduction in wave 2 while those with moderate-to-severe risk remained with elevated scores throughout the follow-up. No interaction effect was observed for other variables. Younger adults and people with chronic diseases reported higher level of anxiety symptoms before the pandemic, as shown in Table 1 ---Insert Table 1 here---Women, younger adults, and people with chronic diseases reported higher levels of depressive symptoms before the pandemic, as shown in Table 2 ---Insert Table 2 here--- This is the first longitudinal state-level study addressing the frequency of depressive and anxiety symptoms over 10 months of the COVID-19 pandemic in Brazil. The country is the current epicenter of the pandemic with a total of 422,340 deaths by May 9 th , 2021, and 53% of them occurred in 2021. We observed that the prevalence of moderate-to-severe symptoms of anxiety and depression did not change significantly compared to wave 1, supporting our initial hypothesis. However, some groups had different trajectories of symptoms in the follow-up period. We identified that depression and anxiety scores remained elevated compared to before the COVID-19 pandemic, despite a reduction from wave 1 to 2. This decreased burden in anxiety and depressive symptoms suggests a populational adaptation to the COVID-19 pandemic situation 15, 26 Depressive symptoms increased in wave 1 but decreased in the subsequent period in some groups. However, in those living alone, the scores from depressive-specific HADS remained elevated compared to before the pandemic, with no significant difference before social distancing (i.e., intercept) and between waves 1 and 2. Social isolation, sometimes wrongly confounded as social distancing, is a leading cause of depression and suicide 28 . While social distancing requires people to keep a safe distance (i.e., 2 meters) from each other and stay at home when possible, social isolation is a lack of social connections. Social isolation might contribute to the risk of future neurological diseases such as dementia 29 . Even though the population must stay-at-home whenever is possible, strategies to improve social activities must be promoted, especially for the vulnerable population such as those living in areas with no internet access 30 . Participants non-symptomatic for anxiety and depression before the pandemic reported an increased frequency of these symptoms during wave 1 followed by a reduction in wave 2. However, the scores in the latest wave remained significantly higher than those observed in the pre-COVID-19 period, suggesting an inverted Jshaped curve in the frequency of symptoms for this group. Based on previous findings 15, 26 , this decrease could be attributable to the development of coping strategies by participants. A similar process was seen in other types of isolation such as incarcerations where a remarkable increase in depressive symptoms is followed by a steady decline 26 . Nevertheless, the prevalence of moderate-to-severe symptoms of anxiety and depression in wave 2 persisted remarkably higher than the period before the COVID-19 pandemic. As previously noted, the easing of some J o u r n a l P r e -p r o o f restrictions might also have stimulated this reduction. However, transmission rate in Brazil was high during wave 2. The weekly switching from less to more severe restrictions (and vice-verse, depending on the situation) might have limited the decrease in the frequency of anxiety and depressive symptoms. It is well-known that this pandemic can trigger an unpredictable increase in the prevalence of depression and anxiety, especially in low and middle-income countries 31 . Until a large proportion of the population get vaccinated, strategies to protect people's mental health need to be promoted by federal, state, and local governments. Some methodological limitations of our study must be acknowledged. First, our retention rate was lower than expected (52% vs 70% 7 ). However, large, populationbased cohort studies found similar or even lower (e.g., 28%) response rates using online-based questionnaires 32 . Second, we used self-reported measurements to evaluate anxiety and depressive symptoms, physical activity, and other variables. Inperson interviews or assessments were not allowed by the local research ethics committee. Third, the retrospective design used during wave 1 may have led to recall bias. Nevertheless, as stated previously, there was no data from large, state-level prospective studies in south Brazil 8 . Fourth, the proportion of participants with an academic degree was overexpressed. While 17% of adults aged 25 years or over had at least one academic degree, this proportion reached 42.4% (95%CI: 37.6% to 47.3%) in our sample. As data collection was online, we expected this sampling bias as less educated people might have limited internet access. However, the COVID-19 has a deeper impact in lower economic groups, so sampling bias is likely to underestimate our occurrence measurements. An interactive web-based dashboard to track COVID-19 in real time Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report Effectiveness of nonpharmaceutical interventions on COVID-19 transmission in 190 countries from 23 Physical distancing interventions and incidence of coronavirus disease 2019 : natural experiment in 149 countries COVID-19 pandemic and mental health consequences: systematic review of the current evidence Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: A systematic review and meta-analysis Longitudinal study about low back pain, mental health, and access to healthcare system during COVID-19 pandemic: protocol of an ambispective cohort Short title: PAMPA cohort: study protocol. medRxiv Sharp increase in depression and anxiety among Brazilian adults during the COVID-19 pandemic: findings from the PAMPA cohort Mental health before and during the COVID-19 pandemic : a longitudinal probability sample survey of the UK population. The Lancet Psychiatry The effect of age, gender, income, work, and physical activity on mental health during coronavirus disease (COVID-19) lockdown in Austria Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations Mental Health Problems during the COVID-19 Pandemics and the Mitigation E ff ects of Exercise : A Longitudinal Study of College Students in China Mental health care and COVID-19. The Lancet Psychiatry Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study. The Lancet Psychiatry Longitudinal changes of anxiety and depressive symptoms during the COVID-19 pandemic in Germany: The role of pre-existing anxiety, depressive, and other mental disorders Using social media for Instituto Brasileiro de Geografia e Estatística (IBGE) Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation study. Health Qual Life Outcomes The Hospital Anxiety and Depression Scale The validity of the Hospital Anxiety and Depression Scale: an updated literature review Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis A Telephone Surveillance System for Noncommunicable Diseases in Brazil Reliability and validity testing of a single-item physical activity measure World Health Organization 2020 guidelines on physical activity and sedentary behaviour Beyond the dichotomy: Incarceration dosage and mental health The psychological impact of quarantine and how to reduce it: rapid review of the evidence Social isolation, loneliness and their relationships with depressive symptoms: a population-based study Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data Internet usage in Brazil COVID-19 and the Need for Action on Mental Health COVID-19 Survey in Five National Longitudinal Studies: Wave 1 User Guide (Version 1) 3) Anxiety symptoms <0.001 <0.001 <0.001 in Hospital Anxiety and Depression Scale (HADS) indicates higher frequency of symptoms. b One observation Anxiety-scores a reported as mean (95%CI) of the HADS scale according to sociodemographic, behavioral, and health-related characteristics of participants in Hospital Anxiety and Depression Scale (HADS) indicates higher frequency of symptoms. b One observation; *p<0.05 compared to pre-COVID-19 period None declared.